Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

2 matching registry records; showing 2 on this page, newest registry updates first. Search checked 2026-11-08 17:30 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2RecruitingINTERVENTIONAL

MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

ClinicalTrials.gov · NCT07505745 · Registry updated: 2026-04-01

Condition / research focus: Prediabetes; Insulin Resistance; Overweight/Obesity
Sponsor: Hudson Biotech
Countries with listed sites: China
Registry dates and results: Start: 2026-02-02. Completion: 2028-05-17 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MOTS-c (MDP) (drug)
Placebo (drug)
Route Subcutaneous injection (other)
Regimen (other)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Peking University Shenzhen HospitalShenzhen, Guangdong, China

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

Explore the world’s study registries

Worldwide

Africa

Americas

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Asia

Middle East

Europe

Oceania